Abstract
Cells sense and respond to extracellular factors via receptors on the cell surface that trigger intracellular signaling pathways. The signals received by the receptors on hematopoietic cells often determine if the cell proliferates, survives or undergoes apoptosis. Apoptosis can be induced by almost any cytotoxic stimuli. These stimuli may be an absence of signals arising from cellular receptors, stimulation of specific ligand receptors on the cell surface, chemotherapeutic agents, and ionizing radiation or oxygen radicals, as well as a number of other factors. Cellular kinases and phosphatases participate in signaling cascades that influence this process. We review the ability of the calmodulin-dependent-kinases, I-κB kinases, PI3-kinases, Jak-kinases, PKC, PKA, and MAP kinase signaling pathways (Erk, Jnk, and p38), to influence the apoptotic process. In addition, we discuss the cross-talk that exists between signaling cascades that are pro-apoptotic and anti-apoptotic.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schwartzman RA, Cidlowski JA . Apoptosis: the biochemistry and molecular biology of programmed cell death Endocr Rev 1993 14: 133–151
Fadok VA, Voelker DR, Campbell PA, Bratton DL, Cohen JJ, Noble PW, Riches DW, Henson PM . The ability to recognize phosphatidylserine on apoptotic cells is an inducible function in murine bone marrow-derived macrophages Chest 1993 103: 102S
Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM . Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells J Immunol 1992 149: 4029–4035
Blagosklonny MV . Cell death beyond apoptosis Leukemia 2000 14: 1502–1508
Allen RT, Cluck MW, Agrawal DK . Mechanisms controlling cellular suicide: role of Bcl-2 and caspases Cell Mol Life Sci 1998 54: 427–445
Adams JM, Cory S . The Bcl-2 protein family: arbiters of cell survival Science 1998 281: 1322–1326
Oltvai ZN, Milliman CL, Korsmeyer SJ . Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell 1993 74: 609–619
Korsmeyer SJ . BCL-2 gene family and the regulation of programmed cell death Cancer Res 1999 59: 1693s–1700s
Nouraini S, Six E, Matsuyama S, Krajewski S, Reed JC . The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-X(L) Mol Cell Biol 2000 20: 1604–1615
Jacotot E, Costantini P, Laboureau E, Zamzami N, Susin SA, Kroemer G . Mitochondrial membrane permeabilization during the apoptotic process Ann NY Acad Sci 1999 887: 18–30
Brenner C, Cadiou H, Vieira HL, Zamzami N, Marzo I, Xie Z, Leber B, Andrews D, Duclohier H, Reed JC, Kroemer G . Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator Oncogene 2000 19: 329–336
Green DR, Reed JC . Mitochondria and apoptosis Science 1998 281: 1309–1312
Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, Casciola-Rosen LA, Rosen A . The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling J Cell Biol 1998 140: 1485–95
Shimizu S, Narita M, Tsujimoto Y . Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC Nature 1999 399: 483–487
Hengartner M . Apoptosis. Death by crowd control Science 1998 281: 1298–1299
Hengartner MO . Apoptosis. Death cycle and Swiss army knives Nature 1998 391: 441–442
Ashkenazi A, Dixit VM . Death receptors: signaling and modulation Science 1998 281: 1305–1308
Pan G, O'Rourke K, Dixit VM . Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex J Biol Chem 1998 273: 5841–5845
Kelekar A, Thompson CB . Bcl-2-family proteins: the role of the BH3 domain in apoptosis Trends Cell Biol 1998 8: 324–330
Haraguchi M, Torii S, Matsuzawa S, Xie Z, Kitada S, Krajewski S, Yoshida H, Mak TW, Reed JC . Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2 J Exp Med 2000 191: 1709–1720
Stoetzer OJ, Pogrebniak A, Scholz M, Pelka-Fleischer R, Gullis E, Darsow M, Nussler V, Wilmanns W . Drug-induced apoptosis in chronic lymphocytic leukemia Leukemia 1999 13: 1873–1880
Konopleva M, Zhao S, Xie Z, Segall H, Younes A, Claxton DF, Estrov Z, Kornblau SM, Andreeff M . Apoptosis. Molecules and mechanisms Adv Exp Med Biol 1999 457: 217–236
Rosen A, Casciola-Rosen L . Macromolecular substrates for the ICE-like proteases during apoptosis J Cell Biochem 1997 64: 50–54
Walter BN, Huang Z, Jakobi R, Tuazon PT, Alnemri ES, Litwack G, Traugh JA . Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity J Biol Chem 1998 273: 28733–28739
Rudel T, Bokoch GM . Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2 Science 1997 276: 1571–1574
Nagata S . Apoptotic DNA fragmentation Exp Cell Res 2000 256: 12–18
Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM . Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J Immunol 1992 148: 2207–2216
Arends MJ, Wyllie AH . Apoptosis: mechanisms and roles in pathology Int Rev Exp Pathol 1991 32: 223–254
Ashkenazi A, Dixit VM . Apoptosis control by death and decoy receptors Curr Opin Cell Biol 1999 11: 255–260
McCubrey JA, May WS, Duronio V, Mufson A . Serine/threonine phosphorylation in cytokine signal transduction Leukemia 2000 14: 9–21
Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA . Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs Leukemia 1999 13: 1109–1166
Hoyle PE, Moye PW, Steelman LS, Blalock WL, Franklin RA, Pearce M, Cherwinski H, Bosch E, McMahon M, McCubrey JA . Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism Leukemia 2000 14: 642–656
Zhuang S, Demirs JT, Kochevar IE . p38 mitogen-activated protein kinase mediates Bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen, but not by hydrogen peroxide J Biol Chem 2000 275: 25939–25948
Lee JE, Sohn J, Lee JH, Lee KC, Son CS, Tockgo YC . Regulation of bcl-2 family in hydrogen peroxide-induced apoptosis in human leukemia HL-60 cells Exp Mol Med 2000 32: 42–46
Mantymaa P, Guttorm T, Siitonen T, Saily M, Savolainen ER, Levonen AL, Kinnula V, Koistinen P . Cellular redox state and its relationship to the inhibition of clonal cell growth and the induction of apoptosis during all-trans retinoic acid exposure in acute myeloblastic leukemia cells Haematologica 2000 85: 238–245
Zhang P, Liu B, Kang SW, Seo MS, Rhee SG, Obeid LM . Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2 J Biol Chem 1997 272: 30615–30618
Kyriakis J, Avruch J . Protein kinase cascades activated by stress and inflammatory cytokines Bioessays 1996 18: 567–577
Maulik N, Sasaki H, Galang N . Differential regulation of apoptosis by ischemia-reperfusion and ischemic adaptation Ann NY Acad Sci 1999 874: 401–411
Sommer D, Fakata KL, Swanson SA, Stemmer PM . Modulation of the phosphatase activity of calcineurin by oxidants and antioxidants in vitro Eur J Biochem 2000 267: 2312–2322
Barrett WC, DeGnore JP, Keng YF, Zhang ZY, Yim MB, Chock PB . Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B J Biol Chem 1999 274: 34543–34546
Imbert V, Peyron JF, Farahi Far D, Mari B, Auberger P, Rossi B . Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases Biochem J 1994 297: 163–173
Ullrich A, Schlessinger J . Signal transduction by receptors with tyrosine kinase activity Cell 1990 61: 203–212
Schlessinger J, Ullrich A . Growth factor signaling by receptor tyrosine kinases Neuron 1992 9: 383–391
Franklin R, Tordai A, Patel H, Gardner A, Johnson G, Gelfand E . Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes J Clin Invest 1994 93: 2134–2140
Tordai A, Franklin R, Patel H, Gardner A, Johnson G, Gelfand E . Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes J Biol Chem 1994 269: 7538–7543
Franklin R, Tordai A, Mazer B, Terada N, Lucas J, Gelfand E . Activation of MAP2-kinase in B lymphocytes by calcium ionophores J Immunol 1994 153: 4890–4898
Nakamura K, Martinez R, Weber M . Tyrosine phosphorylation of specific proteins after mitogen stimulation of chicken embryo fibroblasts Mol Cell Biol 1983 3: 380–390
Cooper J, Sefton B, Hunter T . Diverse mitogenic agents induce the phosphorylation of two related 42 000-dalton proteins on tyrosine in quiescent chick cells Mol Cell Biol 1984 4: 30–37
Cooper J, Hunter T . Major substrate for growth factor-activated protein-tyrosine kinases is a low-abundance protein Mol Cell Biol 1985 5: 3304–3309
Graves J, Campbell J, Krebs E . Protein serine/threonine kinases of the MAPK cascade Ann NY Acad Sci 1995 766: 320–343
Robbins D, Zhen E, Cheng M, Xu S, Ebert D, Cobb M . MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network Adv Cancer Res 1994 63: 93–116
Cobb M, Hepler J, Cheng M, Robbins D . The mitogen-activated protein kinases, ERK1 and ERK2 Semin Cancer Biol 1994 5: 261–268
Cobb M, Goldsmith E . How MAP kinases are regulated J Biol Chem 1995 270: 14843–14846
Cano E, Mahadevan L . Parallel signal processing among mammalian MAPKs Trends Biochem Sci 1995 20: 117–122
Davis R . MAPKs: new JNK expands the group Trends Biochem Sci 1994 19: 470–473
Crews C, Alessandrini A, Erikson R . The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product Science 1992 258: 478–480
Crews C, Erikson R . Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene product Proc Natl Acad Sci USA 1992 89: 8205–8209
Crews C, Erikson R . Extracellular signals and reversible protein phosphorylation: what to Mek of it all Cell 1993 74: 215–217
Payne D, Rossomando A, Martino P, Erickson A, Her J, Shabanowitz J, Hunt D, Weber M, Sturgill T . Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase) EMBO J 1991 10: 885–892
Pelech S, Sanghera J . Mitogen-activated protein kinases: versatile transducers for cell signaling Trends Biochem Sci 1992 17: 233–238
Roovers K, Assoian RK . Integrating the MAP kinase signal into the G1 phase cell cycle machinery Bioessays 2000 22: 818–826
Gardner A, Vaillancourt R, Lange-Carter C, Johnson G . MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity Mol Biol Cell 1994 5: 193–201
Lange-Carter C, Pleiman C, Gardner A, Blumer K, Johnson G . A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf Science 1993 260: 315–319
Guan K . The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus Cell Signal 1994 6: 581–589
Cobb M, Xu S, Hepler J, Hutchison M, Frost J, Robbins D . Regulation of the MAP kinase cascade Cell Mol Biol Res 1994 40: 253–256
Brunet A, Brondello J, L'Allemain G, Lenormand P, McKenzie F, Pages G, Pouyssegur J . MAP kinase module: role in the control of cell proliferation CR Seances Soc Biol Fil 1995 189: 43–57
Howe L, Leevers S, Gomez N, Nakielny S, Cohen P, Marshall C . Activation of the MAP kinase pathway by the protein kinase raf Cell 1992 71: 335–342
Vojtek A, Hollenberg S, Cooper J . Mammalian Ras interacts directly with the serine/threonine kinase Raf Cell 1993 74: 205–214
Van AL, Barr M, Marcus S, Polverino A, Wigler M . Complex formation between RAS and RAF and other protein kinases Proc Natl Acad Sci USA 1993 90: 6213–6217
Lange-Carter C, Johnson G . Ras-dependent growth factor regulation of MEK kinase in PC12 cells Science 1994 265: 1458–1461
Burgering B, de Vries-Smits AM, Medema R, van Weeren PC, Tertoolen L, Bos J . Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways Mol Cell Biol 1993 13: 7248–7256
Graves L, Bornfeldt K, Sidhu J, Argast G, Raines E, Ross R, Leslie C, Krebs E . Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells J Biol Chem 1996 271: 505–511
Seger R, Biener Y, Feinstein R, Hanoch T, Gazit A, Zick Y . Differential activation of mitogen-activated protein kinase and S6 kinase signaling pathways by 12-O-tetradecanoylphorbol-13-acetate (TPA) and insulin. Evidence for involvement of a TPA-stimulated protein-tyrosine kinase J Biol Chem 1995 270: 28325–28330
Gardner A, Vaillancourt R, Johnson G . Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins J Biol Chem 1993 268: 17896–17901
Johnson G, Gardner A, Lange-Carter C, Qian N, Russell M, Winitz S . How does the G protein, Gi2, transduce mitogenic signals? J Cell Biochem 1994 54: 415–422
Kavelaars A, Broeke D, Jeurissen F, Kardux J, Meijer A, Franklin R, Gelfand E, Heijnen C . Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase, and IL-6 production J Immunol 1994 153: 3691–3699
Melamed I, Franklin RA, Gelfand EW . Microfilament assembly is required for anti-IgM dependent MAPK and p90rsk activation in human B lymphocytes Biochem Biophys Res Commun 1995 209: 1102–1110
Kribben A, Wieder E, Li X, van Putten V, Granot Y, Schrier R, Nemenoff R . AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C Am J Physiol 1993 265: C939–945
Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio J, Plowman G, Rudy B, Schlessinger J . Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions Nature 1995 376: 737–745
Rosen L, Ginty D, Weber M, Greenberg M . Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras Neuron 1994 12: 1207–1221
Frey R, Mulder K . Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells Cancer Res 1997 57: 628–633
Chao T, Byron K, Lee K, Villereal M, Rosner M . Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor J Biol Chem 1992 267: 19876–19883
Cuadrado A, Bruder JT, Heidaran MA, App H, Rapp UR, Aaronson SA . H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts Oncogene 1993 8: 2443–2448
Saez R, Chan AM, Miki T, Aaronson SA . Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes Oncogene 1994 9: 2977–2982
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ . Understanding Ras: ‘it ain't over ‘til it's over’ Trends Cell Biol 2000 10: 147–154
Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ . Increasing complexity of Ras signaling Oncogene 1998 17: 1395–1413
Vojtek AB, Der CJ . Increasing complexity of the Ras signaling pathway J Biol Chem 1998 273: 19925–19928
Gire V, Marshall C, Wynford-Thomas D . PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS Oncogene 2000 19: 2269–2276
Bosch E, Cherwinski H, Peterson D, McMahon M . Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 Oncogene 1997 15: 1021–1033
McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E, McMahon M . Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells Leukemia 1998 12: 1903–1929
McCubrey J, Holland G, McKearn J, Risser R . Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms Oncogene Res 1989 4: 97–109
McGlynn AP, Padua RA, Burnett AK, Darley RL . Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells Leuk Res 2000 24: 47–54
Sohur US, Dixit MN, Chen CL, Byrom MW, Kerr LA . Rel/NF-kappaB represses bcl-2 transcription in pro-B lymphocytes Gene Expr 1999 8: 219–229
McCubrey JA, Steelman LS, Moye PW, Hoyle PE, Weinstein-Oppenheimer C, Chang F, Pearce M, White MK, Franklin R, Blalock WL . Effects of deregulated RAF and MEK1 expression on the cytokine-dependency of hematopoietic cells Adv Enzyme Regul 2000 40: 305–337
Moye PW, Blalock WL, Hoyle PE, Chang F, Franklin RA, Weinstein-Oppenheimer C, Pearce M, Steelman L, McMahon M, McCubrey JA . Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells Leukemia 2000 14: 1060–1079
Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M . Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 Mol Cell Biol 1997 17: 5598–6611
Wang HG, Reed JC . Bc1–2, Raf-1 and mitochondrial regulation of apoptosis Biofactors 1998 8: 13–16
Fang X, Yu S, Eder A, Mao M, Bast RC Jr ., Boyd D, Mills GB. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway Oncogene 1999 18: 6635–6640
Yuryev A, Ono M, Goff SA, Macaluso F, Wennogle LP . Isoform-specific localization of A-RAF in mitochondria Mol Cell Biol 2000 20: 4870–4878
Wang HG, Rapp UR, Reed JC . Bcl-2 targets the protein kinase Raf-1 to mitochondria Cell 1996 87: 629–638
Erhardt P, Schremser EJ, Cooper GM . B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway Mol Cell Biol 1999 19: 5308–5315
Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H, McMahon M, McCubrey JA . A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells Oncogene 2000 19: 526–536
Scheid MP, Schubert KM, Duronio V . Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase J Biol Chem 1999 274: 31108–31113
Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME . Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms Science 1999 286: 1358–1362
Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M . CREB and its associated proteins act as survival factors for human melanoma cells J Biol Chem 1998 273: 24884–24890
Tan Y, Ruan H, Demeter MR, Comb MJ . p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway J Biol Chem 1999 274: 34859–34867
Lizcano JM, Morrice N, Cohen P . Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155 Biochem J 2000 349: 547–557
Karmann K, Min W, Fanslow W, Pober J . Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1 J Exp Med 1996 184: 173–182
Derijard B, Hibi M, Wu I, Barrett T, Su B, Deng T, Karin M, Davis R . JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell 1994 76: 1025–1037
Han J, Lee J, Bibbs L, Ulevitch R . A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells Science 1994 265: 808–811
Galcheva-Gargova Z, Derijard B, Wu I, Davis R . An osmosensing signal transduction pathway in mammalian cells Science 1994 265: 806–808
Kyriakis J, Banerjee P, Nikolakaki E, Dai T, Rubie E, Ahmad M, Avruch J, Woodgett J . The stress-activated protein kinase subfamily of c-Jun kinases Nature 1994 369: 156–160
Kyriakis J, Woodgett J, Avruch J . The stress-activated protein kinases. A novel ERK subfamily responsive to cellular stress and inflammatory cytokines Ann NY Acad Sci 1995 766: 303–319
Meier R, Rouse J, Cuenda A, Nebreda A, Cohen P . Cellular stresses and cytokines activate multiple mitogen-activated-protein kinase kinase homologues in PC12 and KB cells Eur J Biochem 1996 236: 796–805
Adler V, Schaffer A, Kim J, Dolan L, Ronai Z . UV irradiation and heat shock mediate JNK activation via alternate pathways J Biol Chem 1995 270: 26071–26077
Lo Y, Wong J, Cruz T . Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases J Biol Chem 1996 271: 15703–15707
Xia Z, Dickens M, Raingeaud J, Davis R, Greenberg M . Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 1995 270: 1326–1331
Lin A, Minden A, Martinetto H, Claret F, Lange-Carter C, Mercurio F, Johnson G, Karin M . Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2 Science 1995 268: 286–290
Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis R, Johnson G, Karin M . Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK Science 1994 266: 1719–1723
Xu S, Robbins D, Frost J, Dang A, Lange-Carter C, Cobb M . MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase Proc Natl Acad Sci USA 1995 92: 6808–6812
Wang HG, Millan JA, Cox AD, Der CJ, Rapp UR, Beck T, Zha H, Reed JC . R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism J Cell Biol 1995 129: 1103–1114
Gallagher AP, Burnett AK, Bowen DT, Darley RL . Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process Cancer Res 1998 58: 2029–2035
Trent JC 2nd, McConkey DJ, Loughlin SM, Harbison MT, Fernandez A, Ananthaswamy HN . Ras signaling in tumor necrosis factor-induced apoptosis EMBO J 1996 15: 4497–4505
Birkenkamp KU, Dokter WH, Esselink MT, Jonk LJ, Kruijer W, Vellenga E . A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation Leukemia 1999 13: 1037–1045
Boldin MP, Goncharov TM, Goltsev YV, Wallach D . Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death Cell 1996 85: 803–815
Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM . FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 1996 85: 817–827
Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM . The regulation of anoikis: MEKK-1 activation requires cleavage by caspases Cell 1997 90: 315–323
Widmann C, Johnson NL, Gardner AM, Smith RJ, Johnson GL . Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1 Oncogene 1997 15: 2439–2447
Chen YR, Meyer CF, Ahmed B, Yao Z, Tan TH . Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1) Oncogene 1999 18: 7370–7377
Low W, Smith A, Ashworth A, Collins M . JNK activation is not required for Fas-mediated apoptosis Oncogene 1999 18: 3737–3741
Chuang TH, Hahn KM, Lee JD, Danley DE, Bokoch GM . The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes Mol Biol Cell 1997 8: 1687–1698
May MJ, Ghosh S . Signal transduction through NF-kappa B Immunol Today 1998 19: 80–88
Baeuerle P, Henkel T . Function and activation of NF-kappa B in the immune system Annu Rev Immunol 1994 12: 141–179
May MJ, Ghosh S . Rel/NF-kappa B and I kappa B proteins: an overview Semin Cancer Biol 1997 8: 63–73
Karin M . How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex Oncogene 1999 18: 6867–6874
Karin M, Ben-Neriah Y . Phosphorylation meets ubiquitination: the control of NF-kappaB activity Annu Rev Immunol 2000 18: 621–663
Baldwin AS Jr . The NF-kappa B and I kappa B proteins: new discoveries and insights Annu Rev Immunol 1996 14: 649–683
Karin M, Delhase M . The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling Semin Immunol 2000 12: 85–98
Beg AA, Baldwin AS Jr . Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor Oncogene 1994 9: 1487–1492
Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr . Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation Mol Cell Biol 1993 13: 3301–3310
Bessho R, Matsubara K, Kubota M, Kuwakado K, Hirota H, Wakazono Y, Lin YW, Okuda A, Kawai M, Nishikomori R et al. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes Biochem Pharmacol 1994 48: 1883–1889
Beg AA, Baltimore D . An essential role for NF-kappaB in preventing TNF-alpha-induced cell death Science 1996 274: 782–784
Wang CY, Mayo MW, Baldwin AS Jr . TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB Science 1996 274: 784–787
Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . Suppression of TNF-alpha-induced apoptosis by NF-kappaB Science 1996 274: 787–789
Liu ZG, Hsu H, Goeddel DV, Karin M . Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death Cell 1996 87: 565–576
Beauparlant P, Kwan I, Bitar R, Chou P, Koromilas AE, Sonenberg N, Hiscott J . Disruption of I kappa B alpha regulation byantisense RNA expression leads to malignant transformation Oncogene 1994 9: 3189–3197
Arsura M, Wu M, Sonenshein GE . TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha Immunity 1996 5: 31–40
Kasibhatla S, Genestier L, Green DR . Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB J Biol Chem 1999 274: 987–992
Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR . DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1 Mol Cell 1998 1: 543–551
Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju ST . Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma J Immunol 1998 161: 3469–3473
Teixeiro E, Garcia-Sahuquillo A, Alarcon B, Bragado R . Apoptosis-resistant T cells have a deficiency in NF-kappaB-mediated induction of Fas ligand transcription Eur J Immunol 1999 29: 745–754
Pyatt DW, Stillman WS, Yang Y, Gross S, Zheng JH, Irons RD . An essential role for NF-kappaB in human CD34(+) bone marrow cell survival Blood 1999 93: 3302–3308
Romano MF, Lamberti A, Bisogni R, Garbi C, Pagnano AM, Auletta P, Tassone P, Turco MC, Venuta S . Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors Blood 1999 94: 4060–4066
Georgescu MM, Kirsch KH, Shishido T, Zong C, Hanafusa H . Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB Mol Cell Biol 1999 19: 1171–1181
Besancon F, Atfi A, Gespach C, Cayre YE, Bourgeade MF . Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein Proc Natl Acad Sci USA 1998 95: 8081–8086
Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS Jr . A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation Genes Dev 1998 12: 968–981
Norris JL, Baldwin AS Jr . Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways J Biol Chem 1999 274: 13841–13846
Chen C, Edelstein LC, Gelinas C . The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L) Mol Cell Biol 2000 20: 2687–2695
Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C . The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis Genes Dev 1999 13: 382–387
Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G . NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes Proc Natl Acad Sci USA 1999 96: 9136–9141
Wang CY, Guttridge DC, Mayo MW, Baldwin AS Jr . NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis Mol Cell Biol 1999 19: 5923–5929
Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, Mayo MW . Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB Mol Cell Biol 2000 20: 1626–1638
Hirano M, Osada S, Aoki T, Hirai S, Hosaka M, Inoue J, Ohno S . MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha J Biol Chem 1996 271: 13234–13238
Hu MC, Wang Y, Qiu WR, Mikhail A, Meyer CF, Tan TH . Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinase Oncogene 1999 18: 5514–5524
Meyer C, Wang X, Chang C, Templeton D, Tan T . Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation J Biol Chem 1996 271: 8971–8976
Ihle JN, Thierfelder W, Teglund S, Stravapodis D, Wang D, Feng J, Parganas E . Signaling by the cytokine receptor superfamily Ann NY Acad Sci 1998 865: 1–9
Ihle JN, Stravapodis D, Parganas E, Thierfelder W, Feng J, Wang D, Teglund S . The roles of Jaks and Stats in cytokine signaling Cancer J Sci Am 1998 4: (Suppl. 1) S84–S91
Ihle JN . STATs: signal transducers and activators of transcription Cell 1996 84: 331–334
Lin TS, Mahajan S, Frank DA . STAT signaling in the pathogenesis and treatment of leukemias Oncogene 2000 19: 2496–2504
Frank DA, Mahajan S, Ritz J . B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues J Clin Invest 1997 100: 3140–3148
Liu RY, Fan C, Garcia R, Jove R, Zuckerman KS . Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines Blood 1999 93: 2369–2379
Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA . A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 1997 278: 1309–1312
Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffe M, Mayeux P, Gouilleux F, Berger R, Gisselbrecht S, Ghysdael J, Bernard OA . Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells Blood 2000 95: 2076–2083
Schuringa JJ, Wierenga AT, Kruijer W, Vellenga E . Constitutive stat3, tyr705, and ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6 Blood 2000 95: 3765–3770
Wilbanks AM, Mahajan S, Frank DA, Druker BJ, Gilliland DG, Carroll M . TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins Exp Hematol 2000 28: 584–593
Sillaber C, Gesbert F, Frank DA, Sattler M, Griffin JD . STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells Blood 2000 95: 2118–2125
Sawyer ST, Jacobs-Helber SM . Unraveling distinct intracellular signals that promote survival and proliferation: study of erythropoietin, stem cell factor, and constitutive signaling in leukemic cells J Hematother Stem Cell Res 2000 9: 21–29
Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD . Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo Proc Natl Acad Sci USA 2000 97: 4227–4232
Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I, Prosper F, Fernandez-Luna JL . Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL J Exp Med 2000 191: 977–984
Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S, Gouilleux F . IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line Oncogene 1999 18: 4191–4199
Richard M, Louahed J, Demoulin JB, Renauld JC . Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction Blood 1999 93: 4318–4327
David M, Petricoin E 3rd, Benjamin C, Pine R, Weber MJ, Larner AC . Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins Science 1995 269: 1721–1723
Stancato LF, Yu CR, Petricoin EF 3rd, Larner AC . Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat1 transcription factor J Biol Chem 1998 273: 18701–18704
Jain N, Zhang T, Fong SL, Lim CP, Cao X . Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK) Oncogene 1998 17: 3157–3167
Goh KC, Haque SJ, Williams BR . p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons EMBO J 1999 18: 5601–5608
Winston LA, Hunter T . Intracellular signalling: putting JAKs on the kinase MAP Curr Biol 1996 6: 668–671
Stancato LF, Sakatsume M, David M, Dent P, Dong F, Petricoin EF, Krolewski JJ, Silvennoinen O, Saharinen P, Pierce J, Marshall CJ, Sturgill T, Finbloom DS, Larner AC . Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway Mol Cell Biol 1997 17: 3833–3840
Sakatsume M, Stancato LF, David M, Silvennoinen O, Saharinen P, Pierce J, Larner AC, Finbloom DS . Interferon gamma activation of Raf-1 is Jak1-dependent and p21ras-independent J Biol Chem 1998 273: 3021–3026
Yamauchi T, Kaburagi Y, Ueki K, Tsuji Y, Stark GR, Kerr IM, Tsushima T, Akanuma Y, Komuro I, Tobe K, Yazaki Y, Kadowaki T . Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase J Biol Chem 1998 273: 15719–15726
Murata T, Husain SR, Mohri H, Puri RK . Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway Int Immunol 1998 10: 1103–1110
Corey S, Eguinoa A, Puyana-Theall K, Bolen JB, Cantley L, Mollinedo F, Jackson TR, Hawkins PT, Stephens LR . Granulocyte–macrophage colony-stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells EMBO J 1993 12: 2681–2690
Minshall C, Arkins S, Dantzer R, Freund GG, Kelley KW . Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors J Immunol 1999 162: 4542–4549
Minshall C, Arkins S, Freund GG, Kelley KW . Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor J Immunol 1996 156: 939–947
Rameh LE, Cantley LC . The role of phosphoinositide 3-kinase lipid products in cell function J Biol Chem 1999 274: 8347–8350
Fruman DA, Meyers RE, Cantley LC . Phosphoinositide kinases Annu Rev Biochem 1998 67: 481–507
Alessi DR, Downes CP . The role of PI 3-kinase in insulin action Biochim Biophys Acta 1998 1436: 151–164
Alessi DR, Cohen P . Mechanism of activation and function of protein kinase B Curr Opin Genet Dev 1998 8: 55–62
Alessi DR, Kozlowski MT, Weng QP, Morrice N, Avruch J . 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro Curr Biol 1998 8: 69–81
Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA . Mechanism of activation of protein kinase B by insulin and IGF-1 EMBO J 1996 15: 6541–6551
Anderson KE, Coadwell J, Stephens LR, Hawkins PT . Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B Curr Biol 1998 8: 684–691
Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J, Hawkins PT . Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B Science 1998 279: 710–714
Franke TF, Kaplan DR, Cantley LC, Toker A . Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate Science 1997 275: 665–668
Songyang Z, Baltimore D, Cantley LC, Kaplan DR, Franke TF . Interleukin 3-dependent survival by the Akt protein kinase Proc Natl Acad Sci USA 1997 94: 11345–11350
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME . Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 1997 91: 231–241
del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt Science 1997 278: 687–689
Kennedy SG, Kandel ES, Cross TK, Hay N . Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria Mol Cell Biol 1999 19: 5800–5810
Majewski M, Nieborowska-Skorska M, Salomoni P, Slupianek A, Reiss K, Trotta R, Calabretta B, Skorski T . Activation of mitochondrial Raf-1 is involved in the anti-apoptotic effects of Akt Cancer Res 1999 59: 2815–2819
Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ . Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt Science 1999 286: 1738–1741
Zimmermann S, Moelling K . Phosphorylation and regulation of Raf by Akt (protein kinase B) Science 1999 286: 1741–1744
Neshat MS, Raitano AB, Wang HG, Reed JC, Sawyers CL . The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf Mol Cell Biol 2000 20: 1179–1186
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC . Regulation of cell death protease caspase-9 by phosphorylation Science 1998 282: 1318–1321
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB . NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase Nature 1999 401: 82–85
Delhase M, Li N, Karin M . Kinase regulation in inflammatory response Nature 2000 406: 367–368
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME . Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 1999 96: 857–868
Medema RH, Kops GJ, Bos JL, Burgering BM . AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 Nature 2000 404: 782–787
McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA, Kaleko M . Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism Blood 1991 78: 921–929
Minshall C, Arkins S, Straza J, Conners J, Dantzer R, Freund GG, Kelley KW . IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors J Immunol 1997 159: 1225–1232
Liu Q, Schacher D, Hurth C, Freund GG, Dantzer R, Kelley KW . Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes J Immunol 1997 159: 829–837
Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R . Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis Mol Cell Biol 1999 19: 7203–7215
Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB . TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes J Immunol 1995 154: 1634–1643
Anderson KL, Anderson G, Michell RH, Jenkinson EJ, Owen JJ . Intracellular signaling pathways involved in the induction of apoptosis in immature thymic T lymphocytes J Immunol 1996 156: 4083–4091
McConkey DJ, Orrenius S, Jondal M . Agents that elevate cAMP stimulate DNA fragmentation in thymocytes J Immunol 1990 145: 1227–1230
McConkey DJ, Orrenius S, Jondal M . Cellular signalling in programmed cell death (apoptosis) Immunol Today 1990 11: 120–121
Vintermyr OK, Gjertsen BT, Lanotte M, Doskeland SO . Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells Exp Cell Res 1993 206: 157–161
Myklebust JH, Josefsen D, Blomhoff HK, Levy FO, Naderi S, Reed JC, Smeland EB . Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression J Cell Physiol 1999 180: 71–80
Hafner S, Adler H, Mischak H, Janosch P, Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M, Kolch W . Mechanism of inhibition of Raf-1 by protein kinase A Mol Cell Biol 1994 14: 6696–6703
Marshall M . Interactions between Ras and Raf: key regulatory proteins in cellular transformation Mol Reprod Dev 1995 42: 493–499
Weissinger E, Eissner G, Grammer C, Fackler S, Haefner B, Yoon L, Lu K, Bazarov A, Sedivy J, Mischak H, Kolch W . Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells Mol Cell Biol 1997 17: 3229–3241
Jun CD, Pae HO, Kim YC, Jeong SJ, Yoo JC, Lee EJ, Choi BM, Chae SW, Park RK, Chung HT . Inhibition of nitric oxide synthesis by butanol fraction of the methanol extract of Ulmus davidiana in murine macrophages J Ethnopharmacol 1998 62: 129–135
Choi BM, Park R, Pae HO, Yoo JC, Kim YC, Jun CD, Jung BH, Oh GS, So HS, Kim YM, Chung HT . Cyclic adenosine monophosphate inhibits ursolic acid-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells Pharmacol Toxicol 2000 86: 53–58
Parvathenani LK, Buescher ES, Chacon-Cruz E, Beebe SJ . Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3 J Biol Chem 1998 273: 6736–6743
Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, Scott JD, Korsmeyer SJ . Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A Mol Cell 1999 3: 413–422
McConkey DJ . The role of calcium in the regulation of apoptosis Scanning Microsc 1996 10: 777–793; discussion 793 – 794
Nicotera P, McConkey DJ, Dypbukt JM, Jones DP, Orrenius S . Ca2+-activated mechanisms in cell killing Drug Metab Rev 1989 20: 193–201
McConkey DJ, Nicotera P, Hartzell P, Bellomo G, Wyllie AH, Orrenius S . Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration Arch Biochem Biophys 1989 269: 365–370
McConkey DJ, Hartzell P, Nicotera P, Orrenius S . Calcium-activated DNA fragmentation kills immature thymocytes FASEB J 1989 3: 1843–1849
Orrenius S, McConkey DJ, Nicotera P . Role of calcium in toxic and programmed cell death Adv Exp Med Biol 1991 283: 419–425
McConkey DJ . Cellular signaling in cell death New Horiz 1993 1: 52–59
McConkey DJ, Jondal M, Orrenius S . Cellular signaling in thymocyte apoptosis Semin Immunol 1992 4: 371–377
McConkey DJ, Hartzell P, Amador-Perez JF, Orrenius S, Jondal M . Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex J Immunol 1989 143: 1801–1806
Rodriguez-Tarduchy G, Collins M, Lopez-Rivas A . Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores EMBO J 1990 9: 2997–3002
Rodriguez-Tarduchy G, Malde P, Lopez-Rivas A, Collins MK . Inhibition of apoptosis by calcium ionophores in IL-3-dependent bone marrow cells is dependent upon production of IL-4+ J Immunol 1992 148: 1416–1422
Baffy G, Miyashita T, Williamson JR, Reed JC . Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production J Biol Chem 1993 268: 6511–6519
Schreiber S, Crabtree G . The mechanism of action of cyclosporin A and FK506 Immunol Today 1992 13: 136–142
Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree G . The mechanism of action of cyclosporin A and FK506 Clin Immunol Immunopathol 1996 80: S40–S45
Waring P, Beaver J . Cyclosporin A rescues thymocytes from apoptosis induced by very low concentrations of thapsigargin: effects on mitochondrial function Exp Cell Res 1996 227: 264–276
Huang QQ, Fang M, Zhang HQ, Xue SB . Cyclosporine inhibited calcium-mediated apoptosis of HL-60 cells Chung Kuo Yao Li Hsueh Pao 1997 18: 262–266
Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC . Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD Science 1999 284: 339–343
Lotem J, Sachs L . Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds Proc Natl Acad Sci USA 1998 95: 4601–4606
Tokumitsu H, Takahashi N, Eto K, Yano S, Soderling TR, Muramatsu M . Substrate recognition by Ca2+/calmodulin-dependent protein kinase kinase. Role of the arg-pro-rich insert domain J Biol Chem 1999 274: 15803–15810
Anderson KA, Means RL, Huang QH, Kemp BE, Goldstein EG, Selbert MA, Edelman AM, Fremeau RT, Means AR . Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta J Biol Chem 1998 273: 31880–31889
Means AR . Regulatory cascades involving calmodulin-dependent protein kinases Mol Endocrinol 2000 14: 4–13
Soderling TR . The Ca-calmodulin-dependent protein kinase cascade Trends Biochem Sci 1999 24: 232–236
Atherfold PA, Norris MS, Robinson PJ, Gelfand EW, Franklin RA . Calcium-induced ERK activation in human T lymphocytes Mol Immunol 1999 36: 543–549
Park I, Soderling T . Activation of Ca2+/calmodulin-dependent protein kinase (CaM-kinase) IV by CaM-kinase kinase in Jurkat T lymphocytes J Biol Chem 1995 270: 30464–30469
Enslen H, Tokumitsu H, Stork P, Davis R, Soderling T . Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade Proc Natl Acad Sci USA 1996 93: 10803–10808
Yano S, Tokumitsu H, Soderling TR . Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway Nature 1998 396: 584–587
McConkey DJ, Hartzell P, Jondal M, Orrenius S . Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C J Biol Chem 1989 264: 13399–13402
McCubrey JA, Steelman LS, Sandlin G, Riddle RS, Ways DK . Effects of phorbol esters on an interleukin-3-dependent cell line Blood 1990 76: 63–72
Mayo MW, Steelman LS, McCubrey JA . Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-jun expression Oncogene 1994 9: 1999–2008
Ways DK, Qin W, Riddle RS, Garris TD, Bennett TE, Steelman LS, McCubrey JA . Differential effect of phorbol esters and interleukin-3 on protein kinase C isoform content and kinase activity in the FDC-P1 cell line Blood 1991 78: 2633–2641
Weinstein-Oppenheimer C, Steelman LS, Algate PA, Blalock WL, Burrows C, Hoyle PE, Lee JT, Moye PW, Shelton JG, Franklin RA, McCubrey JA . Effects of deregulated Raf activation on integrin, cytokine receptor expression and the induction of apoptosis in hematopoietic cells Leukemia 2000 (in press)
Goncalves F, Lacout C, Feger F, Cohen-Solal K, Guichard J, Cramer E, Vainchenker W, Dumenil D . Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines Leukemia 1998 12: 1355–1366
Wada HG, Indelicato SR, Meyer L, Kitamura T, Miyajima A, Kirk G, Muir VC, Parce JW . GM-CSF triggers a rapid, glucose dependent extracellular acidification by TF-1 cells: evidence for sodium/proton antiporter and PKC mediated activation of acid production J Cell Physiol 1993 154: 129–138
Blagosklonny MV, Chuman Y, Bergan RC, Fojo T . Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells Leukemia 1999 13: 1028–1036
Franklin RA, McLeod A, Robinson PJ . Calcium-induced p56(Lck) phosphorylation in human T lymphocytes via calmodulin-dependent kinase Biochem Biophys Res Commun 1999 259: 283–286
Franklin RA, Brodie C, Melamed I, Terada N, Lucas JJ, Gelfand EW . Nerve growth factor induces activation of MAP-kinase and p90rsk in human B lymphocytes J Immunol 1995 154: 4965–4972
Franklin RA, Tordai A, Mazer B, Terada N, Lucas J, Gelfand EW . Platelet activating factor activates MAPK and increases in intracellular calcium via independent pathways in B lymphocytes Biochem Biophys Res Commun 1995 209: 1111–1118
Franklin R, Sawami H, Terada N, Lucas J, Gelfand E . Activation of p42erk2 MAPK and p90rsk by IL-2 occurs independently of protein kinase C Clin Immunol Immunopathol 1996 80: 116–122
Whelan RD, Parker PJ . Loss of protein kinase C function induces an apoptotic response Oncogene 1998 16: 1939–1944
Ruvolo PP, Deng X, Carr BK, May WS . A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis J Biol Chem 1998 273: 25436–25442
Gubina E, Rinaudo MS, Szallasi Z, Blumberg PM, Mufson RA . Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression Blood 1998 91: 823–829
Evans CA, Lord JM, Owen-Lynch PJ, Johnson G, Dive C, Whetton AD . Suppression of apoptosis by v-ABL protein tyrosine kinase is associated with nuclear translocation and activation of protein kinase C in an interleukin-3-dependent haemopoietic cell line J Cell Sci 1995 108: 2591–2598
Datta R, Kojima H, Yoshida K, Kufe D . Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis J Biol Chem 1997 272: 20317–20320
Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, Ghayur T, Wong WW, Kamen R, Weichselbaum R et al. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells EMBO J 1995 14: 6148–6156
Morrow TA, Muljo SA, Zhang J, Hardwick JM, Schlissel MS . Pro-B cell-specific transcription and proapoptotic function of protein kinase C-eta Mol Cell Biol 1999 19: 5608–5618
Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW . A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide Proc Natl Acad Sci USA 1999 96: 9879–9884
Venters HD, Dantzer R, Kelley KW . A new concept in neurodegeneration: TNFalpha is a silencer of survival signals Trends Neurosci 2000 23: 175–180
Acknowledgements
This work was supported by a Scientist Development Grant from the American Heart Association (9930099N), an institutional research grant from the American Cancer Society (IRG-97–149), an Academic Research Initiation Grant from the North Carolina Biotechnology Center (9705-ARG-0009) awarded to RAF, a grant from the National Institutes of Health (R01 CA51025) and Academic Research Initiation Grants from the North Carolina Biotechnology Center (9805-ARG-0006 and 2000-ARG-0003) to JAM. We wish to acknowledge Dr Mikhail Blagosklonny, as well as both reviewers for providing feedback on this manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Franklin, R., McCubrey, J. Kinases: positive and negative regulators of apoptosis. Leukemia 14, 2019–2034 (2000). https://doi.org/10.1038/sj.leu.2401967
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401967
Keywords
This article is cited by
-
Apoptosis and eryptosis: similarities and differences
Apoptosis (2024)
-
Phosphorylation by protein kinase A disassembles the caspase-9 core
Cell Death & Differentiation (2018)
-
Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells
Cell Biology and Toxicology (2012)
-
Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity
Archives of Virology (2011)
-
Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities
Oncogene (2006)